Skip to main content
SteadySharesSteadySharesSteadyStShares
The market
MarketsDiscover
Follow the money
Super InvestorsPolitician TradesCrypto Desk
Yours
My WealthNews
Settings Sign in
Closed
SteadySharesMarketsDiscoverSuper InvestorsMy WealthPoliticiansCryptoNews
DiscoverNEOG
HealthcareNMSUSD

Neogen Corporation

$0012345678900123456789.0012345678900123456789-4.4%
52w low $5.37$14.26 52w high
Market data · updated 31m ago
Market data
Market cap
$2.24B
52w range
$5.37 - $14.26
Beta
1.79
Sector
Healthcare
Data quality
83/100
Valuation
fair value estimate
$9.66
Margin of safety
-21.1%
Forward P/E
34.2x
PEG ratio
0.66
Quality & efficiency
Moat score
32/100
Return on equity
-25.6%
Profit margin
-69.9%
Debt / equity
0.38
Growth & analysts
Revenue growth
-4.4%
Analyst target
$12.00
Target upside
-2.0%
Analysts
3
Run the 10-point checklist before you buy How these numbers are made

About Neogen Corporation

Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through Food Safety and Animal Safety segments. The company offers diagnostic test kits and complementary products to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns for food producers and processors. It also provides reagents and test kits used in immunoassay production, forensic and animal toxicology, and life science research; unique colorimetric and chemiluminescent substrates for research use; veterinary instruments and delivery systems used for administering antibiotics and vaccines under the Ideal and Prima Tech brands; and precision instruments designed for injections, topical and oral administration, artificial insemination, and animal identification for farmers, ranchers, and veterinarian under the Prima Tech brand. In addition, the company offers digestive aids and nutritional supplements; Natural Vitamin E-AD to address vitamin deficiencies in swine, cattle, and sheep; RenaKare; companion animal parasiticides under Provecta brand; BotVax B; EqStim; ImmunoRegulin, used in dogs to assist in managing pyoderma; companion animal parasiticides under the Provecta brand; rodent and insect control products under the Ramik, CyKill, Havoc, Prozap, SureKill, and StandGuard brands. Further, it markets Uniprim, a veterinary antibiotic; operates sgenomics labs offering DNA genotyping, sequencing, and trait analysis for livestock and companion animals; and provides software systems that help testers to analyze and store results and perform analysis on the results from multiple locations over extended periods. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

Valuation

ValueGrowthProfitHealthIncome25QUALITY
Overall Rating
32
Low quality
Low quality

Derived from filed metrics · High confidence (83% of the inputs available)

Moat Score32
Fair value estimate
$9.66-21.1% downside

Moat, fair value and rating computed by our valuation engine (ported from the original Python model).

Fundamentals

Market Cap
$2.24B
P/E Ratio
N/A
Dividend Yield
0.00%
Revenue Growth
-4.4%
Profit Margin
-69.9%
ROE
-25.6%
Debt / Equity
0.38
Beta
1.79

Statistics

Similar Stocks · Healthcare

Latest News · NEOG